Loading...

JHS JHS Svendgaard Laboratories Ltd Other Situations Announcement

JHS

JHS

JHS Svendgaard Laboratories Ltd

(JHS)

2025 Announcement

Show Summary

Show Summary

Management Change

Director Cessation

Annual Compliance Submission

Financial Results Published

Postal Ballot Notice

Board Meeting Outcome

Financial Results Deferred

Management Change

Regulation Compliance

Warrant Acquisition

Financial Results Published

Internal Auditor Appointed

Fund Utilization Report

Postal Ballot Notice

Compliance Certificate

Management Authorizations

Board Meeting Update

Financial Results

Management Change

Funds Utilization Update

Auditor Appointment

Auditor Resignation

RTA Change Announced

SEBI Compliance Certificate

Land Acquisition

Business Expansion

Auditor Appointment

AGM Announcement

Q2 Financial Results

AGM Announcement

Financial Results Released

Fund Raising Announcement

Certificate Submission

Trading Approval

Expansion Announcement

Appointment of Statutory Au...

EGM Announcement

Preferential Issue

Investor Meeting

Investor Presentation

Publication of Financial Re...

Resignation of Auditors

Appointment of Auditor

Acquisition of Subsidiary

Announcement Submission

Earnings Conference Call

Compliance Certificate

Compliance Certificate Anno...

Certificate Submission

Analyst/Investor Meet

Update on Investor Meet

Analyst/Investor Meet Outcome

Investor Meet Notice

Scheme Withdrawal

Meeting Outcome

Investor Conference Call

Financial Results Publication

Cost of Acquisition Apporti...

Certificate Submission

Compliance Certificate

Conference Call Transcript

Newspaper Publication

Conference Call Audio Recor...

Conference Call

Board Meeting Outcomes

Conference Call

Compliance Certificate

Management Resignation

Compliance Certificate Subm...

Scheme of Arrangement Approval

Directorship Cessation

Equity Allotment

Dispatch of AGM Notice

Newspaper Publication

Record Date Fixed

Filing of E-Form INC-28

Arrangement Approval

Financial Statements

Merger of Equals

Scheme of Amalgamation

Certificate Submission

Securities and Exchange Boa...

Equity Offerings

Financial Results Conferenc...

Publication of Financial Re...

Asset Acquisitions

Earnings Conference Call

Compliance Filing

External Links:

Data:

JHS Svendgaard Laboratories reported no deviations in the use of funds raised through a preferential issue totaling Rs. 29.99 crores, with Rs. 19.99 crores from equity shares and Rs. 9.99 crores from convertible warrants for the quarter ended December 31, 2024.

AI Assistant

JHS Svendgaard Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.